Applied Industrial Technologies Inc: Form 10-Q for the period ended Mar 31, 2023
Filed with the SEC on Apr 28, 2023 and accepted by EDGAR at Apr 28, 2023, 10:21 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-01-01 to 2023-03-31 | $1.13bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2022-07-01 to 2023-03-31 | $3.25bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-01-01 to 2023-03-31 | $798.9m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2022-07-01 to 2023-03-31 | $2.31bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2023-01-01 to 2023-03-31 | $333.1m | us-gaap:GrossProfit |
| Gross profit | 9 months2022-07-01 to 2023-03-31 | $948.4m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2023-01-01 to 2023-03-31 | $206.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2022-07-01 to 2023-03-31 | $602.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-01-01 to 2023-03-31 | $126.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2022-07-01 to 2023-03-31 | $346.3m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2023-01-01 to 2023-03-31 | $25.1m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2022-07-01 to 2023-03-31 | $72.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-01-01 to 2023-03-31 | $97.2m | us-gaap:NetIncomeLoss |
| Net income | 9 months2022-07-01 to 2023-03-31 | $254.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-01-01 to 2023-03-31 | $2.47 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2022-07-01 to 2023-03-31 | $6.49 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-01-01 to 2023-03-31 | $2.52 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2022-07-01 to 2023-03-31 | $6.60 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-01-01 to 2023-03-31 | 39,268,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2022-07-01 to 2023-03-31 | 39,203,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2022-07-01 to 2023-03-31 | $164.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2023-01-01 to 2023-03-31 | $8.0m | us-gaap:PaymentsToAcquireProductiveAssets |
| Capital expenditure | 9 months2022-07-01 to 2023-03-31 | $20.8m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 9 months2022-07-01 to 2023-03-31 | $39.8m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2022-07-01 to 2023-03-31 | $716.0k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Current assets | At period end2023-03-31 | $1.51bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-03-31 | $2.61bn | us-gaap:Assets |
| Current liabilities | At period end2023-03-31 | $480.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-03-31 | $1.23bn | us-gaap:Liabilities |
| Long-term debt | At period end2023-03-31 | $597.0m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2023-03-31 | $25.2m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2023-03-31 | $1.38bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000109563-23-000047. Last ingested by Listed: Oct 27, 2026, 21:29 ET. Listed shows no prices and gives no investment advice.